Several key questions remain unanswered and need to be addressed in the future: 1) there is still lacking of large-scale clinical studies to investigate the expression of EIF4F complex components especially different isoforms in NSCLC biopsies, as well as their correlation with tumor stages, histology, metastasis and prognosis. This evidence concerns the gene EIF4A2 and non-small cell lung carcinoma.